Total cholesterol, HDL-cholesterol, and risk of nosocomial infection: A prospective study in surgical patients

Infection Control and Hospital Epidemiology

Volumn 18, Issue 1, 1997, Pages 9-18

  Delgado Rodríguez, Miguel ^a   Medina Cuadros, Marcelino ^b   Martínez Gallego, Gabriel ^b   Sillero Arenas, María ^c  

^a UNIVERSITY OF CANTABRIA   (Spain)

^b Hosp Univ Ciudad de Jaén   (Spain)

^c Provincial Office of Health   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; CHILD; CROSS INFECTION; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; INCIDENCE; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATION; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; REGRESSION ANALYSIS; RISK; RISK FACTOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHOLESTEROL; CHOLESTEROL, HDL; CROSS INFECTION; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; INCIDENCE; MALE; MIDDLE AGED; ODDS RATIO; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS;

EID: 0030638325     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.2307/30141957     Document Type: Article

References (44)

1. Freudenberg MA, Bog-Hansen TC, Back U, Galanos C. Interaction of lipopolysaccharides with plasma high density lipoprotein. Infect Immun 1980;28:373-380.
2. Munford RS, Hall CL, Dietschy DM. Binding of Salmonella typhimurium lipopolysaccharides to rat high density lipoprotein. Infect Immun 1981;34:835-843.
3. Ulevitch RJ, Johnson AR. The modification of biophysical and endotoxic properties of bacterial lipopolysaccharides by serum. J Clin Invest 1978;62:1313-1324.
4. Tobias PS, McAdam KPWJ, Soldau K, Ulevitch RJ. Control of lipopolysaccharide-high density lipoprotein interactions by an acute phase reactant in human serum. Infect Immun 1985;50:73-76.
5. Tobias PS, Soldau K, Ulevitch RJ. Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum. J Exp Med 1986;164:777-793.
6. Ulevitch RJ, Johnson AR, Weinstein DB. New function for high density lipoprotein: their participation in intravascular reactions of bacterial lipopolysaccharides by serum. J Clin Invest 1979;64:1516-1524.
7. Vosbeck K, Tobias P, Mueller H, et al. Priming of polymorphonuclear granulocytes by lipopolysaccharides and its complexes with lipopolysaccharide binding protein and high density lipoprotein. J Leukoc Biol 1990;47:97-104.
8. Wiernik A, Carlson LA, Jarstrand C. High density lipoprotein inhibit the bacterial mediated increase in oxidative metabolism and lysozyme released by neutrophilic granulocytes in vitro. J. Clin Lab Immunol 1986;21:131-135.
9. Owens BJ, Anantharamaiah GM, Kahlon JB, Srinivas RV, Compans RW, Segrest JP. Apolipoprotein A-I and its amphipathic helix peptide analogues inhibit human immunodeficiency virus-induced syncytium formation. J Clin Invest 1990;86:1142-1150.
10. Srinivas RV, Birkedal B, Owens BJ, Anantharamaiah GM, Segrest JP, Compans RW. Antiviral effects of apolipoprotein A-I and its synthetic amphipathic peptides analogs. Virology 1990;176:48-57.
11. Owen JS, Gillett MP, Hughes TE. Transgenic mice expressing human apolipoprotein A-I have sera with modest trypanolytic activity in vitro but remain susceptible to infection by Trypanosoma brucei brucei. J Lipid Res 1992;33:1639-1646.
12. Seed JR, Sechelski JB, Ortiz JC, Chapman JF. Relationship between human serum trypanocidal activity and host resistance to the African trypanosomes. J Parasitol 1993;79:226-232.
13. Verducci G, Perito S, Rossi R, Mannarino E, Bistoni F, Marconi P. Identification of a trypanocidal factor against Trypanosoma equiperdum in normal human serum. Parasitology 1989;98:401-407.
14. Kerttula Y, Weber T. Serum lipids in pneumonia of different etiology. Ann Clin Res 1988;20:184-188.
15. Mukerjee S, Chander R, Tekwani BL, et al. Molecular basis of hyperlipidemia in golden hamsters during experimental infection with Ancylostoma ceylanicum (Nematoda: Strongylidae). Int J Parasitol 1990;20:217-223.
16. Vignon F, Clavert A, Cranz C, Koll-Back MH, Reville P. Alterations in the lipid composition of seminal plasma in patients with a chronic infection of the urogenital tract. Urol Int 1993;50:36-38.
17. Sammalkorpi K, Valtonen V, Kerttula Y, Nikkila E, Taskinen MR. Changes in serum lipoprotein pattern induced by acute infections. Metabolism 1988;37:859-865.
18. Levy E, Gurbindo C, Lacaille F, Paradis K, Thibault L, Seidman E. Circulating tumor necrosis factor-alpha levels and lipid abnormalities in patients with cystic fibrosis. Pediatr Res 1993; 34:162-166.
19. Garbagnati E. Changes in lipid profile observed in children over the course of infectious disease. Acta Paediatr 1993;82: 948-952.
20. Nilsson-Ehle I, Nilsson-Ehle P. Changes in plasma lipoproteins in acute malaria. J Intern Med 1990;227:151-155.
21. Grunfeld C, Pang M, Doerrler W, Shigenaga JK, Jensen P, Feingold KR. Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. J Clin Endocrinol Metab 1992;74:1045-1052.
22. Muga R, Tor J, Rey-Joly C, Pardo A, Llobet P, Foz M. Dislipemia e infección por el VIH-1 en adictos a drogas por vía intravenosa. Med Clin (Barc) 1993;100:161-163.
23. Feingold KR, Hardardottir I, Memon R, et al. Effect of endotoxin on cholesterol biosynthesis and distribution in serum lipoproteins in Syrian hamsters. J. Lipid Res 1993;34:2147-2158.
24. Chen Z, Keech A, Collins R, et al. Prolonged infection with hepatitis B virus and association between low blood cholesterol concentration and liver cancer. BMJ 1993;306:890-894.
25. McCabe WR, Jackson GG. Gram-negative bacteremia: II, clinical, laboratory and therapeutic observations. Arch Intern Med 1962;110:856-864.
26. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections. Am J Infect Control 1988;16:128-140.
27. Haley RW, Quade D, Freeman H, Bennet J, the CDC SENIC Planning Committee. Appendix E: algorithms for diagnosing infections. Am J Epidemiol 1980;111:635-643.
28. Mills JL. Data torturing. N Engl J Med 1993;329:1196-1199.
29. Savitz DA. In defense of black box epidemiology. Epidemiology 1994;5:550-552.
30. Skrabanek P. The emptiness of black box. Epidemiology 1994;5:553-555.
31. Gordis L. Challenges to epidemiology in the next decade. Am J Epidemiol 1988;128:1-9.
32. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic Research. Belmont, CA: Lifetime Learning Publications; 1982.
33. Garibaldi RA, Cushiong D, Lerer T. Risk factors for postoperative infection. Am J Med 1991;91(suppl 3B):158S-163S.
34. Mayhall CG. Surgical infections including burns. In: Wenzel RP, ed. Prevention and Control of Nosocomial Infections. 2nd ed. Baltimore, MD: Williams & Wilkins; 1993:614-664.
35. Flanders WD, Khoury MJ. Indirect assessment of confounding: graphic description and limits on effect of adjusting for covariates. Epidemiology 1990;1:239-246.
36. Jarstrand C, Rasool O. Intralipid decreases the bacterial lipopolysaccharide induced release of oxygen radicals and lysozyme from human neutrophils. Scand J Infect Dis 1991;23:481-487.
37. Harris HW, Grunfeld C, Feingold KR, Rapp JH. Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice. J Clin Invest 1990;86:696-702.
38. Van Lenten BJ, Fogelman AM, Haberland ME, Edwards PA. The role of lipoproteins and receptor-mediated endocytosis in the transport of bacterial lipopolysaccharide. Proc Natl Acad Sci USA 1986;83:2704-2708.
39. Navab M, Hough GP, Van Lenten BJ, Berliner JA, Fogelman AM. Low density lipoproteins transfer bacterial lipopolysaccharides across endothelial monolayers in a biologically active form. J Clin Invest 1988;81:601-605.
40. Haga Y, Sakamoto K, Egami H, et al. Changes in production of interleukin-1 and interleukin-2 associated with obstructive jaundice and biliary drainage in patients with gastrointestinal cancer. Surgery 1989;106:842-848.
41. Galdiero F, Carratelli CR, Nuzzo I, et al. Beneficial effects of myristic, stearic or oleic acid as part of liposomes on experimental infection and antitumor effect in a murine model. Life Sci 1994;55:499-509.
42. Braunwald J, Nonnenmacher H, Pereira CA, Kirn A. Increased susceptibility to mouse hepatitis virus type 3 (MHV3) infection induced by a hypercholesterolemic diet with increased adsorption of MHV3 to primary hepatocyte cultures. Res Virol 1991;142:5-15.
43. US Preventive Services Task Force. Guide to Clinical Preventive Services: An Assessment of the Effectiveness of 169 Interventions. Baltimore, MD: Williams & Wilkins; 1989.
44. Kinosian B, Click H, Garland G. Cholesterol and coronary heart disease: predicting risks by levels and ratios. Ann Intern Med 1994;121:641-647.